START-J: SiTAgliptin in eldeRly Trial in Japan

NCT01183104 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

305

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Sitagliptin
DRUG: Glimepiride

Sponsor

Japan Association for Diabetes Education and Care

Collaborators

[object Object]